Take Advantage of All Pivot Has to Offer
For years, Community of Science (COS) has been recognized around the world for its funding from a wide variety of sources as well as its access to the world’s research community.
CWRU has subscribed to COS's new product, Pivot, which provides you the edge by bringing together the right research opportunities, funding, and people—quickly and easily. It provides global and local connections that strengthen research by exploring new avenues for funding and collaboration—for faculty, staff researchers, and graduate students.
Learn more about how to use all the features Pivot has to offer.
- provide access to the most comprehensive global source of funding opportunities;
- identify research expertise from within or outside of CWRU;
- foster collaboration by cultivating essential partnerships and alliances; and
- build strong network connections for future opportunities.
Sign up for a Pivot Webinar: https://refworks.webex.com/refworks/onstage/g.php?p=4&t=m.
CDC: Minority HIV/AIDS Research Initiative (MARI) to Build HIV Prevention, Treatment and Research Capacity
The overall objective of this teaching/mentored award program is to prepare qualified individuals for careers that have a significant impact on the HIV/AIDS-related research needs of the nation, especially in highly-affected minority communities. The objective of the Minority HIV/AIDS Research Initiative (MARI) Award program is to provide support for a sustained period of time for intensive research training and career development under the guidance of an experienced mentor in HIV prevention research and lead to promising HIV prevention activities and researchers who could independently conduct studies in highly-affected communities.
Application deadline is October 14, 2015
For more information visit the Grants.Gov webpage.
National Multiple Sclerosis Society – Health Care Delivery and Policy Research Contracts
The National Multiple Sclerosis Society announces the following funding opportunities:
• What are the factors related to cost-escalation of MS DMT's and how does the cost of DMT's, particularly out of pocket costs, relate to access to DMT's, payer's policies concerning coverage, initiation of and adherence to therapy, and the ways in which people with MS view the value of treatment? The Society would like to fund this priority in two phases with the cost component on a fast-tracked basis and the value component as a longer-term component.
• What is the extent to which people with MS utilize complementary and alternative medicine? To what extent is this utilization part of an integrative medicine approach that combines mainstream medicine and CAM? What are the policies followed by payers for coverage of CAM independently and as part of integrative medicine?
• What are the barriers preventing access to rehabilitation services, particularly maintenance services among people with MS and what are some of the potential solutions to these barriers?
Letter of Intent Deadline: October 7, 2015
For more information visit the National MS Society webpage.
Department of Defense
The Department of Defense has announced the following new funding opportunities:
Department of the Army - USAMRAA
DoD Gulf War Illness Innovative Treatment Evaluation Award
DoD Gulf War Illness Clinical Trial Award
DoD Gulf War Illness Epidemiology Research Award
DoD Gulf War Illness Investigator-Initiated Research Award
DoD Gulf War Illness New Investigator Research Award
Clinical & Translational Science Collaborative – Career Development Training Opportunity
The Clinical & Translational Science Collaborative (CTSC) KL2 a post-doctoral training program with an emphasis on multidisciplinary clinical and translational research, offers an innovative career development opportunity for qualified candidates.
The CTSC KL2 is designed to train the nation’s future leaders in clinical and translational research, and is part of the NIH Roadmap aimed at “re-engineering the clinical research enterprise.” The CTSC KL2 has just welcomed this year’s cohort of scholars, who were selected from a highly competitive pool of applicants:
- Mohamed Abazeed, MD, PhD (Radiation Oncology; Translational Hematology & Oncology, CCF)
- Stefanie Avril, MD (Pathology, CWRU)
- Nicholas Schiltz, PhD (Epidemiology & Biostatistics, CWRU)
- Jennifer Sweet, MD (Neurosurgery, University Hospitals Case Medical Center)
CTSC KL2 is now seeking applications for next year’s cohort.
Qualified candidates must:
- Hold an MD, PhD, DDS, PharmD, PsyD, or equivalent degree
- Demonstrate a keen interest in clinical research
- Have an appointment in one of the CTSC partner institutions on or before July 1, 2016
- Be a U.S. citizen or have permanent resident status
Each scholar will embark on a 4-year program of intensive training in multidisciplinary team-based, patient-oriented clinical research, combining an innovative curriculum with mentored research experiences.
Applications will be accepted between 7/1/15 and 10/12/15.
For more information, contact Beth Spyke, MPA, at firstname.lastname@example.org / 216.444.2702 or Raed Dweik, MD, at email@example.com / 216-445-5763. You may also request to schedule an information session.
For additional information, visit the CTSC webpage.
If you have news or information that you wish to have included in this
update, please send it via e-mail to Tracy Wilson-Holden at
firstname.lastname@example.org no later than
5 pm on the Monday of the week that the update is to be distributed. If you
know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe
to Case Research News, email your request to Tora Williams at
Please note: At the time of this transmission, all links functioned.
However, Case Research News cannot guarantee that the information will not move or be